Penn Medicine Provider
Gynecologic Oncology
Nawar Latif, MD, MPH, MSCE
4.9
(352)
Accepting new patients
Sees patients age 15 and up
Penn Gynecologic Oncology Washington Square
View 1 additional location
Make an appointmentCall 800-789-7366

About me

  • Surgical Director of the living donor uterus transplant program at Penn
  • Co-Principle investigator of the Uterus Transplant trial
  • Assistant Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Dr. Latif specializes in gynecologic oncology. He serves as an assistant professor of obstetrics and gynecology and as a co-priniciple investigator of the Uterus Transplant for Uterine Factor Infertility (UNTIL) Trial.

Education and training

  • Medical School: Baghdad University Medical School
  • Residency: University of Baghdad
  • Residency: Detroit General Hospital
  • Residency: Northwestern Memorial Hospital
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

352 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
very good doctor
April 2025
5.0
5.0
he is very knowledgeable with his field.
April 2025
5.0
5.0
seemed kind and empathetic and knowledgeable. had answers and explanations to my questions
April 2025
5.0
5.0
felt like i was not being rushed with all my questions. dr is very patient and a good listener.

Insurance accepted

My Locations

Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Latif is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Nasioudis D, Labban N, Gysler S, Ko EM, Giuntoli RL 2nd, Kim SH, Latif NA Outcomes of Radical Hysterectomy for Early-Stage Cervical Carcinoma, with or without Prior Cervical Excision Procedure. , Cancers (Basel), 16(11):2051: 2025

Tubridy E, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D Role of lymphadenectomy for apparent early-stage low-grade serous ovarian carcinoma. , Int J Gynecol Cancer, 35(5):101798: 2025

Mulugeta-Gordon L, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis Quality of adjuvant radiation therapy and impact on the survival of patients with lymph node-positive squamous cell carcinoma of the vulva. , Int J Gynecol Cancer, 101748: 2025

Nasioudis D, Latif NA, Gysler S, Giuntoli RL 2nd, Kim SH, Ko EM Premature adoption of adjuvant chemotherapy for locally advanced cervical carcinoma before the OUTBACK trial: cautionary tale on outcomes. , Int J Gynecol Cancer, 34(12):1874-1880: 2024

Nasioudis D, Labban N, Latif N, Gysler S, Cory L, Kim S, Giuntoli RL 2nd, Ko EM Role of immunotherapy for lymph node positive vulvar melanoma: utilization and outcomes. , Int J Gynecol Cancer, 33(9):1347-1353: 2024

Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection. , Int J Gynecol Cancer, 34(7):969-974: 2024

Nasioudis D, Gysler S, Latif N, Cory L, Giuntoli RL 2nd, Kim SH, Simpkins F, Martin L, Ko EM Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions. , Gynecol Oncol, 180:1-5: 2024

Nasioudis D, Arevalo O, Gysler S, Ko EM, Cory L, Kim SH, Giuntoli RL 2nd, Latif NA Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinoma. , Int J Gynecol Cancer, 34(1):131-137: 2024

Nasioudis D, Wang X, Dhillon G, Latif N, Ko EM, Giuntoli RL 2nd, Gershenson D, Fader A, Carey M, Simpkins F Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery. , Int J Gynecol Cancer, 33(12):1906-1912: 2023

Nasioudis D, Gysler S, Latif NA, Ko EM, Cory L, F Simpkins, Kim SH Utilization and outcomes of sentinel lymph node biopsy (SLNBX) for patients with cervical carcinoma; a multicenter database analysis , Focused ORAL Presentation. International Gynecologic Cancer Society Meeting, Seoul: 2023